(2026). Long-acting injectable cabotegravir/rilpivirine as a second-line ART regimen for pregnant and breastfeeding women in Kenya: Modeling the potential impact on vertical transmission. Open Forum Infectious Diseases.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Long-acting Injectable Cabotegravir/rilpivirine as a Second-line ART Regimen for Pregnant and Breastfeeding Women in Kenya: Modeling the Potential Impact on Vertical Transmission."
Open Forum Infectious Diseases 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Long-acting Injectable Cabotegravir/rilpivirine as a Second-line ART Regimen for Pregnant and Breastfeeding Women in Kenya: Modeling the Potential Impact on Vertical Transmission."
Open Forum Infectious Diseases, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.